Identification of potential therapeutic targets by gene-expression profiling in pancreatic endocrine tumors.

Identification of potential therapeutic targets by gene-expression profiling in pancreatic endocrine tumors.

BACKGROUND and AIMS: Prediction of biological behavior in pancreatic endocrine tumors (PET) is difficult on histologic criteria alone. The aim of this study was to characterize PET gene expression by complementary DNA (cDNA) microarray and identify specific differences in gene-expression profiles b...

Full description

Bibliographic Details
Main Authors:	Couvelard, A, Hu, J, Steers, G, O'Toole, D, Sauvanet, A, Belghiti, J, Bedossa, P, Gatter, K, Ruszniewski, P, Pezzella, F
Format:	Journal article
Language:	English
Published:	2006

Similar Items

Overexpression of the oxygen sensors PHD-1, PHD-2, PHD-3, and FIH Is associated with tumor aggressiveness in pancreatic endocrine tumors.
by: Couvelard, A, et al.
Published: (2008)

Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression.
by: Couvelard, A, et al.
Published: (2005)

Expression of hypoxia-inducible factors is correlated with the presence of a fibrotic focus and angiogenesis in pancreatic ductal adenocarcinomas.
by: Couvelard, A, et al.
Published: (2005)

Pancreatic endocrine tumors with ductules.
by: Chetty, R, et al.
Published: (2005)

Pancreatic endocrine tumors: an update.
by: Chetty, R, et al.
Published: (2004)

CEACAM1 expression in pancreatic endocrine tumors.
by: Serra, S, et al.
Published: (2009)

Pancreatic endocrine tumors with ductules [2] (multiple letters)
by: Chetty, R, et al.
Published: (2005)

Spindle cell pancreatic endocrine tumor associated with Cushing's syndrome.
by: Chetty, R, et al.
Published: (2005)

The predictive value of CK19 and CD99 in pancreatic endocrine tumors.
by: Ali, A, et al.
Published: (2006)

Intracytoplasmic inclusions (including the so-called "rhabdoid" phenotype) in pancreatic endocrine tumors.
by: Serra, S, et al.
Published: (2006)

Angiogenesis in endocrine tumors.
by: Turner, H, et al.
Published: (2003)

Pancreatic endocrine neoplasia: familial syndromes
by: Chetty, R
Published: (2009)

Lipid-rich variant of pancreatic endocrine neoplasms.
by: Singh, R, et al.
Published: (2006)

Asymptomatic children with multiple endocrine neoplasia type 1 mutations may harbor nonfunctioning pancreatic neuroendocrine tumors.
by: Newey, P, et al.
Published: (2009)

Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors.
by: Chetty, R, et al.
Published: (2008)

Molecular Genetic Studies of Pancreatic Neuroendocrine Tumors: New Therapeutic Approaches
by: Stevenson, M, et al.
Published: (2018)

Chromatin-targeting small molecules cause class-specific transcriptional changes in pancreatic endocrine cells
by: Kubicek, Stefan, et al.
Published: (2012)

Mitochondrial dysfunction-targeted nanosystems for precise tumor therapeutics
by: Ma, Zhaoyu, et al.
Published: (2023)

Ultrastructure of pancreatic endocrine cells of the single hump camel (Camelus dromedarius)
by: Bsoul, Manal Khalid, et al.
Published: (2013)

Endocrine-Exocrine Signaling Drives Obesity-Associated Pancreatic Ductal Adenocarcinoma
by: Chung, Katherine Minjee, et al.
Published: (2021)

Pancreatic endocrine tumour with cytoplasmic keratin whorls. Is the term "rhabdoid" appropriate?
by: Chetty, R, et al.
Published: (2004)

Exocrine or endocrine? A circulating pancreatic elastase that regulates glucose homeostasis
by: Gloyn, A
Published: (2019)

Pancreatic endocrine tumour with ductules: further observations of an unusual histological subtype.
by: Chetty, R, et al.
Published: (2006)

Profiling of Target Molecules for Immunotherapy in Mesenchymal Tumors
by: Tonegawa, Susumu
Published: (2020)

iRGD-guided Tumor-penetrating Nanocomplexes for Therapeutic siRNA Delivery to Pancreatic Cancer
by: Lo, Justin H., et al.
Published: (2020)

Tumor penetrating nanomedicine targeting both an oncomiR and an oncogene in pancreatic cancer
by: Gilles, Maud-Emmanuelle, et al.
Published: (2020)

Intraductal pancreatic neuroendocrine tumor.
by: Chetty, R, et al.
Published: (2009)

Ductules in pancreatic neuroendocrine tumors.
by: Chetty, R, et al.
Published: (2004)

Pancreatic endocrine pathology in von Hippel-Lindau disease: an expanding spectrum of lesions.
by: Chetty, R, et al.
Published: (2004)

Phosphorylation of NEUROG3 links endocrine differentiation to the cell cycle in pancreatic progenitors
by: Krentz, NAJ, et al.
Published: (2017)

Molecular therapeutics of pancreatic ductal adenocarcinoma:targeted pathways and the role of cancer stem cells
by: Stoica, A, et al.
Published: (2020)

Tumor necrosis factor-alpha: a promising therapeutic target for asthma?
by: Heffler, E, et al.
Published: (2007)

Lack of Association for Reported Endocrine Pancreatic Cancer Risk Loci in the PANDoRA Consortium.
by: Campa, D, et al.
Published: (2017)

Apj+ vessels drive tumor growth and represent a tractable therapeutic target
by: Zhao, H, et al.
Published: (2018)

Bromodomains as therapeutic targets.
by: Muller, S, et al.
Published: (2011)

Cytokines as therapeutics and targets of therapeutics
by: Vilček, J, et al.
Published: (2006)

Comparison of four target volume definitions for pancreatic cancer. Guidelines for treatment of the lymphatics and the primary tumor.
by: Fokas, E, et al.
Published: (2013)

ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation
by: Fokas, E, et al.
Published: (2013)

Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.
by: Fokas, E, et al.
Published: (2012)

Cancer therapeutic study utilizing fluorescent bioimaging probe targeting tumor initiating cells
by: Tan, Corrina Zi Ting, et al.
Published: (2023)